Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Performer
2807.1000 32.70 (1.18%)
NSE May 12, 2025 15:31 PM
Volume: 158.8K
 

2807.10
1.18%
Emkay
DLPL reported a steady Q4, with EBITDA beating street/our estimates by 6% and adj PAT improving 34% on YoY basis. Strong performance in core markets (Delhi NCR), buoyed by network expansion, offset the persistent muted performance of Suburban (mid-single digit revenue growth).
Dr. Lal Pathlabs Ltd. is trading below its 150 day SMA of 2875.1
More from Dr. Lal Pathlabs Ltd.
Recommended